Positioning Tivozanib in Today’s RCC Treatment Landscape

18 Visioni
Published
Medical oncologists review standard-of-care treatments and therapy goals for patients with advanced RCC after first-line TKI or immunotherapy regimens.

Follow us on social media:
•⁠ ⁠X/Twitter: https://twitter.com/oncbrothers
•⁠ ⁠Instagram: https://www.instagram.com/oncbrothers
•⁠ Website: https://oncbrothers.com/
•⁠ Main Channel: https://www.youtube.com/@UCjfxKlVho5xWH5ltufj4F4A
Categoria
Oncology
Commenta per primo questo video.